about
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeksPhysiologic adaptation of endothelial function to pregnancy: a systematic review and meta-analysis.Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis.Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)Development and Measurement of Guidelines-Based Quality Indicators of Caesarean Section Care in the Netherlands: A RAND-Modified Delphi Procedure and Retrospective Medical Chart ReviewA protocol of a randomized controlled multicenter trial for surgical treatment of lumbar spondylolisthesis: the Lumbar Interbody Fusion Trial (LIFT).Subsequent Pregnancy after Preterm Prelabor Rupture of Membranes before 27 Weeks' Gestation.Metamizole versus ibuprofen at home after day surgery: study protocol for a randomised controlled trial.Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women.Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer.Predicting successful intended vaginal delivery after previous caesarean section: external validation of two predictive models in a Dutch nationwide registration-based cohort with a high intended vaginal delivery rate.Involving women in personalised decision-making on mode of delivery after caesarean section: the development and pilot testing of a patient decision aid.Outcome of pregnancies with preterm prelabor rupture of membranes before 27 weeks' gestation: a retrospective cohort study.External Validation and Modification of a Predictive Model for Acute Postsurgical Pain at Home After Day Surgery.Anatomical Cystocele Recurrence: Development and Internal Validation of a Prediction Model.A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters.Prevalence of asymptomatic heart failure in formerly pre-eclamptic women: a cohort study.Comparison of translabial three-dimensional ultrasound with magnetic resonance imaging for measurement of levator hiatal biometry at rest.Obstetric anal sphincter injury: a follow-up questionnaire study on longer-term outcomes.Multicenter impact analysis of a model for predicting recurrent early-onset preeclampsia: A before-after study.The Relation between Duration of Ruptured Membranes and Perinatal Outcome in Patients with Midtrimester Prelabor Rupture of Membranes.Maternal cardiac adaptation to subsequent pregnancy in formerly pre-eclamptic women according to recurrence of pre-eclampsia.Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome.Re: "Differences in Risk Factors for Recurrent Versus Incident Preterm Delivery".Hypertension after preeclampsia is preceded by changes in cardiac structure and function.Vaginal birth after a caesarean section: the development of a Western European population-based prediction model for deliveries at term.A model for preconceptional prediction of recurrent early-onset preeclampsia: derivation and internal validation.External validation of a model for periconceptional prediction of recurrent early-onset preeclampsiaIndex Event Bias: Problems with Eliminating the ParadoxEarly Pregnancy Circulatory Adaptation and Recurrent Hypertensive DiseaseIndex event bias—a numerical exampleAge-Related Alterations in Cardiac Geometry in Formerly Preeclamptic Women and Healthy Parous Controls: An Explorative StudyPredicting the Coexistence of an Endometrial Adenocarcinoma in the Presence of Atypical Complex HyperplasiaA limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohortsSerial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht
P50
Q24200570-0F5F2460-4651-485C-9F26-8B9E9188311FQ30236014-6DE3CE54-3993-45BF-8F6F-1DE9C58C9B76Q33713398-DFE7A461-B1DE-4EE2-82E4-5B61B0AEBA19Q33936671-B5E5B204-9D0E-4FDD-A661-5961F27E6542Q34414996-C1CD785D-0F8C-4F6F-9185-F6AFDB0AF4C9Q35141224-6B26791C-C87B-4563-9FD0-82594810B840Q35897424-0DF69737-8C35-4ECE-8556-F9021EF49F74Q36156986-47736649-7B4C-4924-8BBB-95A4FE090C12Q37237347-5C8BC4ED-9255-44C7-82C1-760FAA762A21Q37286099-AD5CCE26-4A1B-412A-AFB0-AD6E1E21D0B7Q39142729-7E0971C3-0AE7-4D88-8AF5-25A4C7388A00Q39169040-D9723EED-C57D-41AC-AA79-A8A809DA170FQ39249567-B232F29F-BB56-4E34-9C50-0E16BC904348Q39283759-A995562A-197B-4568-AA5E-CBC67C2EB4FFQ39386556-8E20E0F6-0311-47D2-A78B-D1CF7508EA10Q39591190-3EF5219C-E02D-49DA-9D75-07F92425D10DQ39948526-1D9C8D39-C9E5-426E-AD62-51B56EB03AC6Q40556006-E91C207F-F97B-4DCD-910D-E27CB10C65C6Q40655618-D5C5D634-EA11-448A-B891-B998FAB47310Q40733553-C096E986-3C54-46FA-857A-8BB1D3740E91Q40796570-7107C2CD-43D0-42F4-B4BC-2B0CE4B008ABQ40917024-BB6A562F-074F-47BD-B1CC-DF7FE2EF2644Q40944002-EC0A8460-FB92-4938-B338-6C8F89710CF7Q41332779-9E638AC3-411B-43C5-A4D4-4680CAAA7606Q43694394-6FFB784A-A581-4987-8E25-EC4C9340535AQ45135799-050A14C2-9B6C-457A-9E4A-C10F37DE106BQ46156559-FA75EABA-455F-4EA2-B56D-2D03DAF135B5Q50699614-3E598FC5-9A2B-45C3-9995-A2280A26C54CQ51372056-6CD2C116-5CEB-4D86-A381-B2546D22DDB2Q58623821-ADBB91FF-FD37-4FA5-8523-E15DAE53FD10Q58832114-4072AC6E-C719-4FFC-B5AC-51D4382C7DB8Q58832120-2FC7D5B1-C899-435A-9BF6-F77111D8CC68Q58832125-724A6D1E-7241-4498-ABB3-4509E7704D9DQ58832128-BFDA6E24-E689-4496-A2EE-CB373FC196BCQ58832132-DFA77A89-BBFC-431E-9B07-C2ED32A7A548Q89533609-F0356EA2-FD58-4B6A-B2E2-3440B2116CECQ95621988-416321C9-A726-496E-87B0-DF770C48E0AB
P50
description
researcher ORCID ID = 0000-0003-2796-729X
@en
wetenschapper
@nl
name
Sander van Kuijk
@ast
Sander van Kuijk
@en
Sander van Kuijk
@es
Sander van Kuijk
@nl
type
label
Sander van Kuijk
@ast
Sander van Kuijk
@en
Sander van Kuijk
@es
Sander van Kuijk
@nl
prefLabel
Sander van Kuijk
@ast
Sander van Kuijk
@en
Sander van Kuijk
@es
Sander van Kuijk
@nl
P106
P31
P496
0000-0003-2796-729X